These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 21756155

  • 21. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A, Menter A, Armstrong A, Ocampo C, Gu Y, Teixeira HD.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1192-1196. PubMed ID: 27741335
    [Abstract] [Full Text] [Related]

  • 22. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
    Leslie KS, Tripathi SV, Nguyen TV, Pauli M, Rosenblum MD.
    J Am Acad Dermatol; 2014 Feb 01; 70(2):243-51. PubMed ID: 24314876
    [Abstract] [Full Text] [Related]

  • 23. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
    Ann Intern Med; 2012 Dec 18; 157(12):I-50. PubMed ID: 23247950
    [No Abstract] [Full Text] [Related]

  • 24. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA.
    J Am Acad Dermatol; 2010 Feb 18; 62(2):205-17. PubMed ID: 20115947
    [Abstract] [Full Text] [Related]

  • 25. Treatment of hidradenitis suppurativa with biologic medications.
    Lee RA, Eisen DB.
    J Am Acad Dermatol; 2015 Nov 18; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
    Alhusayen R, Shear NH.
    Am J Clin Dermatol; 2012 Oct 01; 13(5):283-91. PubMed ID: 22676319
    [Abstract] [Full Text] [Related]

  • 27. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
    van Rappard DC, Mooij JE, Baeten DL, Mekkes JR.
    Br J Dermatol; 2011 Jul 01; 165(1):194-8. PubMed ID: 21428974
    [Abstract] [Full Text] [Related]

  • 28. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA.
    Semin Arthritis Rheum; 2011 Apr 01; 40(5):398-406. PubMed ID: 20843542
    [Abstract] [Full Text] [Related]

  • 29. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.
    Noda S, Mizuno K, Adachi M.
    J Dermatol; 2012 Mar 01; 39(3):265-8. PubMed ID: 22126280
    [Abstract] [Full Text] [Related]

  • 30. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL, Singh MN, Chalmers RJ.
    Dermatol Online J; 2010 Aug 15; 16(8):15. PubMed ID: 20804692
    [Abstract] [Full Text] [Related]

  • 31. Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease.
    Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall W, Carvalho RS, Mack DR, Hyams JS.
    Am J Gastroenterol; 2009 Dec 15; 104(12):3042-9. PubMed ID: 19724267
    [Abstract] [Full Text] [Related]

  • 32. Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.
    Shikiar R, Heffernan M, Langley RG, Willian MK, Okun MM, Revicki DA.
    J Dermatolog Treat; 2007 Dec 15; 18(1):25-31. PubMed ID: 17365264
    [Abstract] [Full Text] [Related]

  • 33. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL, Lowe L, Kang S.
    J Dermatolog Treat; 2005 Feb 15; 16(1):58-61. PubMed ID: 15897171
    [Abstract] [Full Text] [Related]

  • 34. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.
    Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, Steen DW.
    Cornea; 2010 Oct 15; 29(10):1189-91. PubMed ID: 20628295
    [Abstract] [Full Text] [Related]

  • 35. Use of biological treatments in patients with hidradenitis suppurativa.
    Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M, Ferran M, Sánchez-Regaña M, Collgros H, Bordas X, Notario J, Alsina M, Gil I, Izquierdo N, Aparicio G, Mollet J, Garcia-Patos V, Pujol RM.
    J Eur Acad Dermatol Venereol; 2015 Jan 15; 29(1):56-60. PubMed ID: 24629001
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
    DE Oliveira JP, Levy A, Morel P, Guibal F.
    J Dermatol; 2008 Sep 15; 35(9):575-80. PubMed ID: 18837702
    [Abstract] [Full Text] [Related]

  • 37. Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.
    Schabert VF, Bruce B, Ferrufino CF, Globe DR, Harrison DJ, Lingala B, Fries JF.
    Curr Med Res Opin; 2012 Apr 15; 28(4):569-80. PubMed ID: 22236091
    [Abstract] [Full Text] [Related]

  • 38. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D, Padilla B, Izquierdo JA, Fernández-Cruz E, Sánchez-Ramón S.
    Arch Dermatol; 2010 Dec 15; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract] [Full Text] [Related]

  • 39. Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study.
    Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):787-96. PubMed ID: 17373917
    [Abstract] [Full Text] [Related]

  • 40. Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis.
    Walsh CA, Minnock P, Slattery C, Kennedy N, Pang F, Veale DJ, Bresnihan B, FitzGerald O.
    Rheumatology (Oxford); 2007 Jul 01; 46(7):1148-52. PubMed ID: 17478471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.